Serum interleukin-8 and insulin like growth factor-1 in Egyptian bladder cancer patients

Cancer Biomarkers

Volumn 6, Issue 2, 2009, Pages 105-110

  Mahmoud, Moushira A ^a   Ali, Mohamed H ^a   Hassoba, Howayda M ^a   Elhadidy, Gehan S ^b  

^a Suez Canal University Faculty of Medicine   (Egypt)

^b SUEZ CANAL UNIVERSITY   (Egypt)

Author keywords

bladder cancer; insulin like growth factor 1; Interleukin 8; schistosomal infection

Indexed keywords

INTERLEUKIN 8; SOMATOMEDIN C; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EGYPT; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCHISTOSOMIASIS; SENSITIVITY AND SPECIFICITY;

AGED; EGYPT; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-8; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; SCHISTOSOMIASIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 77954106044     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2009-0133     Document Type: Article

References (45)

1. A. Jemal, R. Siegel, E.Ward, T. Murray, J. Xu and M.J. Thun, Cancer statistics, 2007, CA Cancer J Clin 57 (2007), 43-66.
2. A. Li, S. Dubey, M.L. Varney, B.J. Dave and R.K. Singh, IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis, J Immunol 170 (2003), 3369-3376.
3. A. Macri, A. Versaci, S. Loddo, G. Scuderi, M. Travagliante, G. Trimarchi, D. Teti and C. Famulari, Serum levels of interleukin 1beta, interleukin 8 and tumour necrosis factor alpha as markers of gastric cancer, Biomarkers 11 (2006), 184-193.
4. A. Nacinovíc-Duletíc, S. Stifter, S. Dvornik, Z. Skunca and N. Jonjíc, Correlation of serum IL-6, IL-8 and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma, Int J Lab Hematol 30 (2008), 230-239.
5. A. Zlotnik and O. Yoshie, Chemokines: a new classification system and their role in immunity, Immunity 12 (2000), 121-127.
6. A.D. Luster, Chemokines-chemotactic cytokines that mediate inflammation, N Engl J Med 338 (1998), 436-445.
7. A.M. Nomura, G.N. Stemmermann, J. Lee and M.N. Pollak, Serum insulin-like growth factor I and subsequent risk of colorectal cancer among Japanese-American men, AmJ Epidemiol 158 (2003), 424-431.
8. A.S. Ibrahim and H.M. Khaled, Urinary Bladder Cancer, in: Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER, L.S. Freedman, B.K. Edwards, L.A.G. Ries and J.L. Young, eds, NIH Pub. No. 06- 5873. Bethesda, MD., 2006, PP. 97-110.
9. B.J. Rollins, Chemokines, Blood 90 (1997), 909-928.
10. B.M. Mian, C.P.N. Dinney, C.E. Bermejo, P. Sweeney, C. Tellez, X.D. Yang, J.M. Gudas, D.J. McConkey and M. Bar- Eli, Fully Human Anti-Interleukin 8 Antibody Inhibits Tumor Growth in Orthotopic Bladder Cancer Xenografts via Down- Regulation of Matrix Metalloproteases and Nuclear Factor- ?B, Clin Cancer Res 9 (2003), 3167-3175.
11. C. Busch and F. Algaba, The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer: scientific foundation and translation to one another and previous systems, Virchows Arch 441 (2002), 105-108.
12. D. LeRoith, H.Werner, D. Beitner-Johnson and C. T. Roberts, Molecular and cellular aspects of the insulin-like growth factor I receptor, Endocr Rev 16 (1995), 143-163.
13. E. Sheryka, M.A. Wheeler, D.A. Hausladen and R.M. Weiss, Urinary Interleukin-8 levels are elevated in subjects with transitional cell carcinoma, Urology 62 (2003), 162-166.
14. G. Pignot, I. Bieche, S. Vacher, C. Güet, A. Vieillefond, B. Debŕe, R. Lidereau and D. Amsellem-Ouazana, Large-scale Real-time Reverse Transcription-PCR Approach of Angiogenic Pathways in Human Transitional Cell Carcinoma of the Bladder: Identification of VEGFA as a Major Independent Prognostic Marker, Eur Urol 56 (2009), 678-688.
15. H.Kocak, Y. Oner-Iyidogan, T.Kocak and P. Oner, Determination of diagnostic and prognostic values of urinary interleukin- 8, tumor necrosis factor-a, and leukocyte arylsulfatase-A activity in patients with bladder cancer, Clin Bioch 37 (2004), 673-678.
16. H. Yu, F. Jin, X.O. Shu, B.D. Li, Q. Dai, J.R. Cheng, H.J. Berkel and W. Zheng, Insulin-like growth factors and breast cancer risk in Chinese women, Cancer Epidemiol Biomarkers Prev 11 (2002), 705-712.
17. H. Zhao, H.B. Grossman, M.R. Spitz, S.P. Lerner, K. Zhang and X. Wu, Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk, J Urol 169 (2003), 714-717.
18. H.Z. Sun, S.F.Wu and Z.H. Tu, Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity, Cell Res 11 (2001), 107-115.
19. I. Desbaillets, A.C. Diserens, N. Tribolet, M.F. Hamou and E.G. Van Meir, Upregulation of interleukin 8 by oxygendeprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis, J Exp Med 186 (1997), 1201-1212.
20. I.D. Fleming, J.S. Cooper and D.E. Henson, TNM staging of the urinary bladder, in: AJCC Cancer Staging Manual, I.D. Fleming, ed., Lippincot-Raven, Philadelphia PA, 1997, pp. 241-243.
21. I.H. Benoy, R. Salgado, P. Van Dam, K. Geboers, E. Van Marck, S. Scharpe, P.B. Vermeulen and L.Y. Dirix, Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival, Clin Cancer Res 10 (2004), 7157-7162.
22. J. Kaminska, M.P. Nowacki, M. Kowalska, A. Rysinska, M. Chwalinski, M. Fuksiewicz, W. Michalski and M. Chechlinska, Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I-an independent prognostic factor, Tumour Biol 26 (2005), 186-194.
23. J.I. Jones and D.R. Clemmons, Insulin-like growth factors and their binding proteins: biological actions, Endocr Rev 16 (1995), 3-34.
24. K. Inoue, J.W. Slaton, S.J. Kim, P. Perrotte, B.Y. Eve, M. Bar-Eli, R. Radinsky and C.P. Dinney, Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer, Cancer Res 60 (2000), 2290-2299. (Pubitemid 30225196)
25. K. Matsushima and J. Oppenheim, Interleukin-8 and MCAF: novel inflammatory cytokines inducible by IL-8 and TNF, Cytokine 1 (1989), 2-12.
26. K. Xie, Interleukin-8 and human cancer biology, Cytokine Growth Factor Rev 12 (2001), 375-391.
27. K.B. Adler, B.M. Fischer, D.T. Wright, L.A. Cohn and S. Becker, Interactions between respiratory epithelial cells and cytokines: relationships to lung inflammation, Ann N Y Acad Sci 725 (1994), 128-145.
28. K.K. Huff, D. Kaufman, K.H. Gabbay, E.M. Spencer, M.E. Lippman and R.B. Dickson, Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells, Cancer Res 46 (1986), 4613-4619.
29. M. Ghoneim, M. El-Mekresk, M. El-Baz, I. El-Attar and A. Ashmallah, Radical cystectomy for carcinoma of the bladder, critical evaluation of the results in 1026 cases, J Urol 158 (1997), 393-399. (Pubitemid 27327674)
30. M. Iwamura, M. Ishibe, P.M. Sluss and A.T.K. Cockett, Characterization of insulin-like growth factor binding sites in human bladder cancer cell lines, Urol Res 21 (1993), 27-32. (Pubitemid 23058764)
31. M. Rochester, N. Patel, G. Hellawell, S. Brewster and V. Macaulay, The role of the type 1 insulin-like growth factor receptor in bladder cancer, Eur Urol Suppl 2 (2003), 52.
32. M.A. Rochester, N. Patel, B.W. Turney, D.R. Davies, I.S. Roberts, J. Crew, A. Protheroe and V.M. Macaulay, The type 1 insulin-like growth factor receptor is over-expressed in bladder cancer, BJU Int 100 (2007), 1396-1401
33. M.L. Serrano, M. Sanchez-Gomez and M.M. Bravo, Insulinlike growth factor system gene expression in cervical scrapes from women with squamous intraepithelial lesions and cervical cancer, Growth Horm IGF Res 17 (2007) 492-499.
34. M.N. Pollak, E.S. Schernhammer and S.E. Hankinson, Insulinlike growth factors and Neoplasia, Nat Rev Cancer 4 (2004), 505-518.
35. P. Cohen, Overview of the IGF-I system, Horm Res 65(Suppl 1) (2006), 3-8.
36. P. Rotwein, K.M. Pollock, D.K. Didier and G.G. Krivi, Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides, J Biol Chem 261 (1986), 4828-4832.
37. Q.X. Xie, X.C. Lin, M.F. Zhang, C.X. Han and Y.H. Guo, Expression of IGF-I and IGF-IR in bladder cancer, Ai Zheng 23 (2004), 707-709.
38. R.M. Strieter, P.J. Polverini, S.L. Kunkel, D.A. Arenberg, M.D. Burdick, J. Kasper, J. Dzuiba, J. Van Damme, A. Walz, D. Marriott, S.-Y. Chan, S. Roczniak and A.B. Shanafelt, The functional role of the ELR motif in CXC chemokine-mediated angiogenesis, J Biol Chem 270 (1995), 27348-27357.
39. S. Lehrer, E.J. Diamond, B. Mamkine, N.M. Stone and R.G. Stock, Serum interleukin-8 is elevated in men with prostate cancer and bone metastases, Technol Cancer Res Treat 3 (2004), 411.
40. S.E. Dunn, F.W. Kari, J. French, J.R. Leininger, G. Travlos, R. Wilson and J.G. Barrett, Dietary restriction reduces insulinlike growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice, Cancer Res 57 (1997), 4667-4672.
41. S.E. Oliver, D. Gunnell, J. Donovan, T.J. Peters, R. Persad, D. Gillatt, A. Pearce, D.E. Neal, F.C. Hamdy and J. Holly, Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study, Int J Cancer 108 (2004), 887-892. (Pubitemid 38112619)
42. S.F. Shariat, J. Kim, C. Nguyen, T.M. Wheeler, S.P. Lerner and K.M. Slawin, Correlation of preoperative plasma levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer, Urology 61 (2003), 359-364.
43. T.A. Serel, T. Turan, S. Soyupek, Z. Aybek and H. Perk, Urine and serum free IGF-1 levels in patients with bladder cancer: a brief report, Urol Res 31 (2003), 297-299.
44. T. Karashima, P. Sweeney, A. Kamat, S. Huang, S.J. Kim, M. Bar-Eli, D.J. McConkey and C.P. Dinney, Nuclear factorkappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8, Clin Cancer Res 9 (2003), 2786-2797.
45. X. Wu, G. Tortolero-Luna, H. Zhao, D. Phatak, M.R. Spitz and M. Follen, Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix, Clin Cancer Res 9 (2003), 3356-3361.